Maureen E. Trudeau

Cost-effectiveness of the 21-gene assay for guiding adjuvant chemotherapy decisions in early breast cancer.

Mike Paulden, Murray Krahn, B. Pham, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of respon

John M.L. Ebos, Mark Clemons, Robert Buckman, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quantitative ultrasound evaluation of tumor cell death response in locally advanced breast cancer patients to chemotherapy treatment administration

Martin J. Yaffe, Gregory J. Czarnota, Michael C. Kolios, 2013 .

The association between the transfer of emergency department admitted patients to inpatient hallways and outcomes of oncology patients

M. Trudeau, S. Singh, K. Imrie, 2015 .

Quantitative ultrasound assessment of breast tumor response to chemotherapy using a multi-parameter approach

Gregory J. Czarnota, Ali Sadeghi-Naini, Lakshmanan Sannachi, 2016, Oncotarget.